Versant Capital Management’s AtriCure ATRC Stock Holding History

Versant Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.29K	Sell	46 -139	-75%	-$3.91K	﹤0.01%	2616
2026 Q1	$5.28K	Buy	185 +139	+302%	+$4.74K	﹤0.01%	2365
2025 Q4	$1.82K	Hold	46	–	–	﹤0.01%	2459
2025 Q3	$1.62K	Hold	46	–	–	﹤0.01%	2442
2025 Q2	$1.51K	Hold	46	–	–	﹤0.01%	2434
2025 Q1	$1.48K	Hold	46	–	–	﹤0.01%	2311
2024 Q4	$1.41K	Hold	46	–	–	﹤0.01%	2127
2024 Q3	$1.29K	Sell	46 -40	-47%	-$986	﹤0.01%	1681
2024 Q2	$1.96K	Buy	86 +79	+1,129%	+$1.82K	﹤0.01%	1516
2024 Q1	$213	Buy	+7	New	+$234	﹤0.01%	1825

Other funds holding ATRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Versant Capital Management's ATRC Position: Q2 2026 in Review

Versant Capital Management reduced its AtriCure (ATRC) stake by 75% in Q2 2026, selling an estimated $3.91K and leaving 46 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2616.

Versant Capital Management first reported a position in ATRC in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.28K in Q1 2026. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

Versant Capital Management held 46 shares of AtriCure worth $1.29K as of Q2 2026.
Versant Capital Management sold 139 AtriCure shares in Q2 2026, an estimated $3.91K.
AtriCure made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2616 holding.
Versant Capital Management first reported a position in AtriCure in Q1 2024 and has held it in 10 quarters since.
Versant Capital Management's AtriCure position peaked at $5.28K in Q1 2026.
251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.